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Abstract 
The aim of this study was to compare approaches commonly recommended in the literature for the 
improvement of the survival of probiotics in the human digestive tract. The survival of two probiotics, 
L. casei W56 and B. lactis W52, in the presence or absence of prebiotics, maize starch, fermented milk 
and upon encapsulation in calcium alginate-chitosan were evaluated. While B. lactis W52 was resistant 
to stomach juice, but sensitive to duodenal juice, L. casei W56 showed an exactly opposite behaviour. 
Overall the digestive survivability of probiotics was not improved by prebiotics, maize starch or 
encapsulation. A significant improvement of the overall survivability of B. lactis W52 (but not L. casei 
W56) during in vitro digestion was noted in milk and fermented milk, possibly due to reduction of the 
activity of bile against this probiotic. Overall no one method could be recommended universally for the 
improvement of probiotic survivability. Nevertheless, this research indicated that certain probiotic 
characteristics, such as susceptibility to bile or acid or ability to use matrix components as an energy 
source could perhaps be used in further research to select the most effective approaches to deliver viable 
cells into lower parts of the digestive tract.  
Highlights 
• L. casei W56 was sensitive to stomach and B. lactis W52 to duodenum juice  
• L. casei W56 during in vitro digestion survived worse than B. lactis W52 
• Fermented milk and milk facilitated survival of B. lactis W52 but not L. casei W56  
• Prebiotics, starch and encapsulation did not improve survival of probiotics 
• Susceptibility of probiotics to bile or acid may be indicative of the effective approach    
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1. Introduction 
Consumers are increasingly interested in the influence of diet on health (Dianawati et al., 2016). One 
class of “healthy ingredients” increasingly added to foods are probiotics, the global consumption of 
probiotics is increasing and probiotic foods are thought to comprise up to 70% of total functional foods 
market (Tripathi and Giri, 2014). 
Probiotics are defined as a “live microorganisms that, when administered in adequate amounts, confer 
a health benefit on the host” (Hill et al., 2014; Joint FAO/WHO Working Group, 2002). Up to date 
research indicates that probiotics may improve wellbeing in multiple ways e.g.:  
  
• inhibition of the growth of pathogenic bacteria via lowering intestinal pH or by competition 
(Oelschlaeger, 2010; Timmerman et al., 2004),  
• reduction of body mass index and waist circumference (Sun and Buys, 2015) 
• improvement of glucose and lipid homeostasis (Kasińska and Drzewoski, 2015; Sun and Buys, 
2015), 
• prevention and treatment of antibiotic-associated and infectious diarrhoea (Allen et al., 2010; 
Hempel et al., 2012)  
• improvement of overall symptom response in irritable bowel syndrome therapy (Zhang et al., 
2016)  
• prevention of necrotising enterocolitis in pre-term infants (Alfaleh et al., 2011)  
• prevention of infantile eczema (Zuccotti et al., 2015) 
• decrease of incidence of respiratory tract infections in children (Wang et al., 2016) 
 
To confer these health benefits, it is often assumed that probiotics need to be viable. So, if administrated 
orally, probiotics need to pass through a sequence of human digestive system compartments that 
intrinsically pose a challenge to their survival (Babiloni et al., 2004; Uriot et al., 2016). The two main 
obstacles hampering survival are the low pH of stomach juice and the action of bile salts (Bezkorovainy, 
2001).   
Published data indicate that survivability of the probiotics in the human digestive tract varies between 
species and even between strains of species. Published papers suggest up to 10 log reductions for 
probiotic populations upon exposure to digestive juices (Kingwatee et al., 2014). 
To date a number of studies have investigated how the survivability of probiotics in passing through 
the digestive tract be improved. The results of these studies indicate that this could be achieved by 
application of a food matrix or addition of prebiotic to either supplement or encapsulate the 
formulations.  
Foods can protect probiotics during digestion in different ways and this is an area of ongoing research. 
Of importance is the buffering capacity of foods, which could ensure a safe passage of probiotics 
through stomach (Lo Curto et al., 2011). Further, particular food ingredients, may aid survival by 
various mechanisms. For example, metabolizable sugars have been shown to improve the tolerance of 
L. rhamnosus GG to acid by provision of an energy source for the exclusion of protons from cells 
(Corcoran et al., 2005). Soy protein added to fermented soy milk results in the aggregation of bile salts, 
limiting the action of bile against probiotics (Ranadheera et al., 2010). Furthermore, in several studies, 
the protective effect of foods containing fat has been demonstrated (Govender et al., 2013; Tompkins 
et al., 2011). Another factor that has been implied in the improvement of probiotic survival may be 
growth within the food matrix. Lo Curto et al. (2011) reported that probiotics challenged with digestive 
juices had up to 6 log cfu higher log reduction in the growth phase compared to the stationary phase. 
Food fermented with probiotics e.g. milk, will contain cells in the stationary phase, whilst if the 
probiotic powder is freshly introduced to the food, cells may only start to multiply prior to digestion. 
Hence, a difference would be expected between survival of probiotics administered into digestive tract 
in fresh and fermented milk.  
Another group of compounds that has been shown to effectively improve the survivability of probiotics 
are prebiotics (Kingwatee et al., 2014; Sanchez et al., 2014). Prebiotics are defined as a “a substrate that 
is selectively utilized by host microorganisms conferring a health benefit” (Gibson et al., 2017).  To 
date only a few compounds are considered prebiotics. Substances such as inulin and products of its 
degradation such as fructans (oligofructose), lactulose and trans/galacto/fructo-oligosaccharides (TOS, 
GOS and FOS), match these criteria (Roberfroid, 2008; Roberfroid et al., 2010).  
Besides the addition of various compounds to the probiotic loaded ingestable matrix, published research 
also examined the limitation of exposure of probiotics to digestive juices by encapsulation. Such 
capsules need to be made of a food-grade material that will enable release of the probiotics in the 
intestines (Picot and Lacroix, 2004). There are a number of substances that may be used for the probiotic 
encapsulation (see review by Burgain et al. (2011)). Among them, a popular choice is calcium alginate. 
The material is available as a food grade, and it has been demonstrated to dissolve in intestinal 
conditions (Segale et al., 2016). However, calcium alginate tends to create porous capsules, which may 
mean that the probiotics would not be protected from the contact with digestive juices (Burgain et al., 
2011). It has been shown that coating calcium alginate capsules with chitosan enables enhancement of 
the probiotic survival in digestive juices (Shori, 2017).  
Besides a selection of suitable encapsulation material, an important factor is the size of produced 
capsules. The evidence in published literature suggests that if the capsules are too small (<100 µm) 
viability during digestion may not improved (Khosravi Zanjani et al., 2014).  
 A number of methods of encapsulation may be used (Burgain et al., 2011). One novel method being 
increasingly applied in research studies is electrospraying, where an electrostatic field is used to draw 
polymer solution through a spinneret resulting in the formation of a spray discharge of small droplets 
(Coghetto et al., 2016). This method is more suitable for use with probiotics than some other methods, 
such as spray-drying, as it does not use high temperatures. 
Despite the extensive research on the improvement of probiotic survival during the passage through 
gastro-intestinal tract it is not clear which solutions could be practically implemented. For example, it 
is not known if the beneficial effects described to date would be observed in other probiotic strains. An 
additional complication is a lack of the uniformity in digestive models used in the various studies - 
dynamic and static systems with varying pH, digestion time, chemicals and their concentrations have 
been examined, which makes comparison of data difficult. Furthermore, studies on comparison of 
different approaches for the improvement of the digestive survivability of probiotics are scarce. Studies 
that do exist are typically focused on the investigation of combined effects of tested approaches e.g. 
prebiotics or other food substance combined with encapsulation or comparison of survivability of 
different probiotic strains in commercial formulations featuring varying matrices (Fredua-Agyeman and 
Gaisford, 2015; Shori, 2017). Such studies, although provide very valuable information, do not allow a 
conclusion as to whether there is a method of choice that could be applied to improve the digestive 
survivability of probiotics in general. 
This research aims to compare three methods that were shown to improve probiotic survival in other 
studies: 
1. Inclusion of the food matrix (fresh and fermented milk, maize starch) 
2. Application of the probiotic at different concentration levels (inulin and FOS) 
3. Encapsulation in calcium alginate coated with chitosan by means of electrospraying 
For the comparison of both method efficacy, and transferability to different probiotic strains we have 
chosen two probiotics, L. casei W56 and B. lactis W52, which according to the manufacturer’s data 
exhibit different responses to gastro intestinal conditions. We confirmed that these two probiotics show 
very different behaviour when exposed digestive liquids. While L. casei W56 was sensitive to stomach 
juice, B. lactis W52 was reasonably resistant to stomach juice, but unstable in duodenum juice. Thanks 
to these differences it was possible to test the protective effect of studied here approaches to probiotics 
in both stomach and duodenal conditions. These two compartments of the human digestive tract pose a 
great challenge to the effective survival of probiotics. Hence, the approach which would be generally 
recommended as improving probiotic survival should display a good protective effect in both stomach 
and duodenal conditions. Testing whether such approach was available among those recommended in 
the literature was a subject of this study.   
 
2. Materials  
Two probiotic strains used in the study, B. lactis W52 and L. casei W56, in a powdered form, were 
obtained from Winclove Probiotics (Amsterdam, Netherlands). Based on in-house experiments 
conducted by Winclove Probiotics, it was expected that B. lactis W52 survived the in vitro digestion 
better compared to L. casei W56. Freeze-dried organisms were kept at 4°C prior to use. Prebiotics FOS 
(FOS P1, Winclove Probiotics, Amsterdam, Netherlands) and inulin (inulin & FOS P7, Winclove 
Probiotics Amsterdam, Netherlands) as well as a maize starch carrier material used in commercial 
probiotic supplements were also supplied by Winclove Probiotics. Full fat milk (composition per 100 
ml: fat 3.6 g, sugar 4.7 g and protein 3.4 g; pH 6.8) was purchased from a local supermarket. 
Sodium chloride, sodium bicarbonate, potassium chloride, calcium chloride, porcine pepsin, porcine 
pancreatin and porcine bile used for digestive assaying were obtained from Fisher (Loughborough, UK). 
Sodium alginate, chitosan and calcium carbonate used in probiotic encapsulation were obtained from 
Avonchem limited (Macclesfield Cheshire, UK), Acros Organics (Morris Plains, USA) and Fisher 
(Loughborough, UK) respectively. 
3. Methods 
3.1 Preparation of samples challenged by in vitro digestion 
Probiotic powders were combined with prebiotic or maize starch by mixing in sterile tap water. 
Probiotics were added aseptically in a quantity allowing to obtain concentration of cells in the sample 
prior to digestion above 8 log cfu/ ml (count of viable cells in each sample was presented in the result 
section). This is the level recommended as a probiotic daily therapeutic dose (Kailasapathy and Chin, 
2000).  
To allow resuscitation of probiotics, samples were kept for 15 min at room temperature prior to analysis 
and the start of the digestion simulation. The concentrations of prebiotics in water suspensions were 
0.1, 0.5, 1 and 5% and maize starch 5%. The highest concentration of prebiotic was chosen to reflect 
the dose that was previously shown to have a beneficial effect to the human health (Kellow et al., 2014). 
Fermented milk was prepared by the incubation of sterile milk (150 ml) with the addition of ~ 0.1 g of 
probiotic powder with either L. casei W56 or B. lactis W52 for 18 h at 40 ˚C. The pH of milk following 
fermentation was 4.3 for L. casei W56 and 4.7 for B. lactis W52. Control samples contained only sterile 
tap water and probiotics. 
For encapsulation, probiotics were mixed into a 2.25% sodium alginate solution. Probiotics were either 
added to the sodium alginate as a supplied freeze-dried powder (~ 0.1 g of powder to 5 ml of alginate; 
powder) or upon previous resuscitation (broth). The resuscitation was carried out by subsequently  
1. Inoculating 150 mL de Man Rogosa Sharpe (MRS) broth with ~ 0.1 g of probiotic powder and 
incubating for 24 hours at 37°C (B. lactis was grown in MRS broth supplemented with 0.05% L-
cysteine),  
2. Harvesting cells from 40 ml of the broth by centrifugation at 1500 g for 15 min at 25 °C,  
3. Washing and centrifuging the pellet twice with saline solution using same settings as in step 2 and  
4. Re-suspending the pellet in 3 ml of saline solution and adding to 20 ml of alginate solution.  
Suspensions of probiotics in sodium alginate were then electrosprayed. The electrospraying process has 
been explained in the previous publications (Zaeim et al., 2017). The equipment used for 
electrospraying was shown in Figure 1a and was provided by Electospinz Ltd (Blenheim, New 
Zealand). The set up was composed of a polymer dispenser, a needle with a 0.06 mm diameter and a 
dish collector grounded through a crocodile clip. The solution was electrosprayed at 8 kV and the 
distance between the needle and the collector was 8 cm. The polymer/ probiotic solution was placed in 
the reservoir and flowed under gravity to the needle. Droplets were electrostatically attracted into a dish 
collector which contained 500 mM calcium carbonate solution at pH 5.2. About 0.5 g of calcium 
alginate droplets encapsulating probiotics were obtained during a single 2 h run. Capsules were then 
filtered through a filter paper (Whatman no 4, Fisher, Loughborough, UK), rinsed with sterile water 
and further coated with chitosan. 
For coating, 20 mg of chitosan was dissolved in 2 ml of 10% glacial acetic acid and the pH was raised 
to ~ 6.0 by adding 0.5 M NaOH. Alginate micro beads were immersed in the chitosan solution and 
stirred at 60 RPM for 40 min using an orbital shaker (LSE, Corning, New York, US). This procedure 
was adapted from a method by Sohail et al., (2010) (Sohail et al., 2011).  
Coated capsules were then filtered, washed twice with sterile water and placed in a fresh portion of 
sterile water. The capsule suspension was stored for up to 2 days at 4 °C prior to digestion assay. 
Capsules were prepared in triplicate and characterised by means of the optical microscope (MOTIC B1 
Advanced Series with Motic Images Plus version 3 software for image analysis). An example image of 
these capsules is shown in Figure 1b. Capsules measured between ~500 to 800 µm and on average 660 
µm. This was much greater than 100µm, the size below which survival could not be facilitated 
(Khosravi Zanjani et al., 2014). Prepared capsules contained probiotics at a level of > 6 log cfu/g.  
 Figure 1- a. electrospinning equipment and b. light microscopy image of capsules made by electrospraying. 
3.2 In vitro digestion model 
To investigate the survivability of probiotics in the human digestive tract in the presence or absence of 
prebiotic maize starch and fermented milk, a model designed based on several studies was applied. The 
composition and proportions of the digestive juices were adapted from studies of Marteau et al., (1997) 
and Timmerman et al. (2007) (Marteau et al., 1997; Timmerman et al., 2007) and are given in Table 1. 
Stomach and duodenal juice were prepared and warmed to 37 °C prior to experimentation. Artificial 
digestion was carried out at 37 ˚C with a constant agitation using an orbital shaker (LSE, Corning, New 
York, US) at 60 RPM.  
Table 1. Composition of simulated stomach and duodenal juice 
Chemicals 
 
g/l 
NaCl NaHCO3 KCl CaCl2 
porcine 
pepsin 
porcine 
pancreatin 
porcine 
bile 
Stomach 6.2 1.2 2.2 0.22 3.2 X X 
Duodenum 5 x 0.6 0.25 x 9 14 
 
Several preliminary trials of the digestion design were performed to ensure survivability of the probiotic 
suspended in water (control) on a level above the limit of detection for our enumeration method.  
In the selected protocol, settings were chosen to reflect a wide range of realistic conditions in the human 
digestive tract – as described for example by Guerra et al., (2012) (Guerra et al., 2012) as well as these 
used in other in vitro digestion studies that trialled probiotic survivability (Kingwatee et al., 2014; 
Timmerman et al., 2004). The model is shown in Figure 2. Chosen transit times were 30 min in the 
stomach, 1 h in the duodenum and 2 h in the ileum. The pH during digestion was 2 for stomach and 6.5 
for duodenum stage. Ileal juice was simulated by addition of 11.5 mM of CaCl2 to the duodenum juice 
to deactivate bile salts. Anaerobiosis during the digestion was created by overlying digestive liquids 
with 5 ml of mineral oil. Anaerobiosis has applied only in recent artificial digestion studies on the 
survival of probiotics, nevertheless it is a realistic condition present in the digestive tract. In our 
preliminary assessment is that we saw a better survival of the microorganisms, especially L. casei W56 
in the stomach juice, when anaerobiosis was applied. 
Samples were added in 5 ml aliquots, where ~ 0.5 g of the capsules were weighed and added to digestive 
juices with 5 ml of sterile deionised water. The pH of digestive juices was measured and re-adjusted 
upon the addition of the samples. 
In vitro digestion for each sample was repeated 3 times. 
 
Figure 2. Schematic representation of the design of the in vitro digestion assay used in this study 
3.3 Enumeration of probiotics 
Samples were analysed using ISO 15214 (1998). First, samples were serially diluted in buffered peptone 
water (BPW, Oxoid, Basingstoke, England, CM0509) and targeted dilutions were the transferred in 
volume of 1 ml to empty petri dishes.  Then, ~ 15 ml of de Man, Rogosa, Sharpe agar (MRS, Oxoid, 
Basingstoke, England, CM0361), which had been sterilised and cooled to below 50 ˚C, was poured to 
the petri dishes and mixed with the sample aliquots. Unsupplemented MRS agar was used for L. casei. 
For B. lactis MRS agar contained 0.05% of L-cysteine.  Medium was allowed to solidify and plates 
were then incubated at 37°C for 72h in 15% CO2, <1% O2 and N2 atmosphere created with the 
MULTIVAC T200 tray sealer (Multivac, Wolfertschwenden, Germany). The limit of detection for the 
method was 1 cfu/ml of digestive juice. Results below the limit of detection were included in statistical 
analysis as 0.5 cfu/ml. 
The calcium alginate-chitosan capsules were visually intact through the entire digestion process. Hence, 
prior to enumeration, cells were released from the capsules. This was carried out by stirring 
encapsulated probiotics in 10 ml of 0.1 M phosphate buffer at pH 7 at room temperature for 30 minutes. 
The release of the probiotics from capsules has been confirmed by preliminary trials, where count of 
viable cells was determined at different time points during mixing. 
3.4 Data analysis 
Statistical tests were performed using IBM SPSS Statistics 22. All assumed a significance level of 0.05. 
Particular tests were mentioned in the result section with the relevant data.  
All log reduction values quoted in the text and shown in the figures were corrected for the dilution 
factors caused by the addition of stomach and duodenum juice to the samples within the digestive assay. 
4. Results 
Survival curves of L. casei W56 and B. lactis W52 during passage through digestive liquids in control 
sample, as well as in the presence of prebiotics, food matrices and in encapsulates is shown in Figure 
3. Based on the presented graphs for control samples it is clear that the population of L. casei W56 
declined sharply in stomach and B. lactis W52 in duodenum juice.  
Statistical tests (repeated measures ANOVA with Bonferroni post-hoc, for all measurements 
disregarding matrix, data were performed, but are not presented in the figures), indicated that stages in 
the digestion process had a significant effect on the log reduction of probiotic population. The digestion 
stage where the largest log reduction occurred was stomach for L. casei W56 (mean log reduction ± 
standard deviation, 4.4 ± 1.1 log cfu) and duodenum for B. lactis W52 (3.9 ± 1.9 log cfu). At the same 
time L. casei W56 seemed relatively resistant to duodenum juice (0.6  ± 1.4 log cfu) and B. lactis W52 
to stomach juice (0.5  ± 0.5 log cfu). The ileum juice offered the most gentle conditions for both 
probiotics (0.2  ± 1.1 and -0.7  ± 1.2 log cfu for L. casei W56 and B. lactis W52 respectively, the 
negative log reduction indicates growth). 
For L. casei W56 survival curves representing control, food matrices and all levels of prebiotics 
followed a similar pattern. Encapsulated L. casei W56 reduced at similar rates through all digestive 
stages. In turn, B. lactis W52 behaved similarly to the control when probiotic was challenged to 
digestive assay in the presence of maize starch, prebiotics at all concentration levels as well as within 
capsules containing probiotic powder. The survival curve of B. lactis W52 in the presence of milk and 
fermented milk as well as upon encapsulation of the broth-grown probiotics, was linear, meaning that 
the decline of the probiotics was similar through all the digestion stages. Out of these three treatments 
encapsulation of the broth-grown probiotics seemed to feature a steeper decline for the population of B. 
lactis W52 compared to when the probiotic was challenged in milk or fermented milk. 
The presented survival curves are real log cfu/ml counts disregarding the dilution of the probiotics by 
addition of stomach and duodenum juices. To compare the effectiveness of different approaches total 
log reductions (upon challenge to complete in vitro digestion assay), where these dilution factors were 
corrected for, were subjected to statistical evaluation (see Figure 4).  
Total log reduction (upon challenge to complete in vitro assay) for L. casei W56 ranged from 4.2 to 7.4 
log cfu (milk and capsules containing broth-grown probiotics respectively) and for B. lactis W52 from 
1.0 to 5.1 log cfu (fermented milk and capsules containing probiotic powder respectively).  For L. casei 
W56 there was no treatment which reduced the total log reduction significantly compared to control. 
However, encapsulation of broth-grown probiotics caused a significant increase of the total log 
reduction compared to control and all other treatments. On the other hand the a significantly greater 
survival of B. lactis W52 was obtained in the presence of milk and fermented milk compared to control 
and all the other treatments.  
Overall, mean total log reductions were significantly higher for L. casei W56 compared to B. lactis 
W52 (paired for treatments t-test, p<0.05) indicating that B. lactis W52 was more resistant to conditions 
of the digestive tract than to L. casei W56. This was in line with the suggestion given by the probiotic 
provider as specified in the method section. 
 
Figure 3. Survival during in vitro digestion of L. casei W56 and B. lactis W52 in presence and absence of food matrices, inulin, 
FOS and in capsules). Errors bars correspond to standard deviation. The counts are expressed per ml of initial solution. The 
dilution created by the addition of juices during the experiment were not compensated for. 
  
Figure 4. Total log reduction for   L. casei W56 and  B. lactis W52 after challenge complete in-vitro assay. Columns 
note mean values and error bars standard deviations. Different letters above different columns in the same in vitro digestion 
part of a same graph mean significant differences between different matrices and/ or control (ANOVA and Tukey post-hoc, 
significance level of 0.05). 
5. Discussion 
5.1 The effect of probiotic type on the survival during in vitro digestion 
 This study evaluated survivability of two different probiotic bacteria, L. casei W56 and B. lactis 
W52 in human digestive juices. It has been suggested that these two probiotic species might exhibit 
contrasting survival in a simulated human digestive tract although it should be noted that each of these 
works used a different in vitro digestion design (Fávaro-Trindade and Grosso, 2002; Kingwatee et al., 
2014; Lo Curto et al., 2011).  
Here, by application of one in vitro digestion design for both probiotic species, we had an opportunity 
to verify the difference in survival. We have found that overall B. lactis W52 survived better the in vitro 
digestion compared to L. casei W56. Nevertheless, the magnitude of the differences in survival was 
affected by the type of the matrix surrounding the probiotics.  
We have also noticed that L. casei W56 and B. lactis W52 behaved very differently in different digestive 
juices. L. casei W56 was sensitive to stomach juice and resistant to duodenum juice, while B. lactis 
W52 on the contrary was mostly reduced in the duodenum juice. A similar behaviour of L. casei 01 was 
previously documented by Kingwatee et al. (2014). However, B. lactis Bb12 was shown to have a high 
resistance to bile salts in contrast to our results B. lactis W52 (Fávaro-Trindade and Grosso, 2002). This 
suggested that not only species but also specific strain type affect the survival of probiotic in the 
digestive tract as demonstrated previously, for example for L. plantarum (van Bokhorst-van deVeen et 
al., 2012).  
5.2 The effect of the presence of food matrices on the survival of 
probiotics during in vitro digestion 
The presence of the food matrix, such as milk may substantially improve the survival of 
probiotics, several authors note the fat in the food matrix as an element which could potentially enhance 
probiotic survival (Govender et al., 2013; Tompkins et al., 2011). For example, Tompkins et al. (2011) 
showed that probiotics (ProtecFlor®, a commercial supplement containing 4 probiotic strains) survived 
better in 1% fat milk and oats compared to fruit juice and spring water. Nevertheless, this study did not 
focus on specific probiotic strains and did not compare efficacy of the treatment for each specific 
probiotic strain. In turn, Lo Curto et al (2011) showed that the digestive survivability of two different 
probiotics: L. casei immunitas and L. acidophilus johnsonii was improved in the presence of the whole 
milk matrix compared to water by 6.5 and 1 log cfu respectively. This finding indicated that different 
probiotics may not be equally protected by fat. In the present study, food matrices containing fat, milk 
and fermented milk, improved significantly the survival of B. lactis W52 (on average by 3.6 and 3.7 
log cfu respectively), but not that of L. casei W56 (on average by 1.3 and 0.0 log cfu respectively). 
Since B. lactis W52 was sensitive to duodenum juice while L. casei W56 was comparatively resistant 
to it, results might point at the role of fat in the protection of probiotics from bile. Given that the task 
of bile is to emulsify the fat to aid its digestion, inclusion of fat into probiotic matrix could mean that 
the bile salts would not be free to interact with probiotic cells (Begley et al., 2005). 
Based on the published literature it was expected that fermentation of milk might add to the 
protective effect of the food matrix through  
1. Possible acid adaptation, especially of stomach juice sensitive L. casei W56 and  
2. Propagation of the probiotic population from logarithmic growth phase into stationary phase. 
Improvement of acid resistance could be expected, since the pH of fermented milk was lower than that 
of fresh milk (4.3 and 6.8 respectively) indicating the production of lactic acid by fermentation. 
Nevertheless, in our study, the digestive survival of L. casei W56 was on average worse (although not 
significantly) in fermented milk compared to milk (total log reduction 5.5 and 4.2 log cfu respectively). 
This result did not support the development of acid resistance in stomach juice sensitive probiotic. In 
contrast development of acid adaptation was demonstrated for L. acidophilus LA-5 and L. rhamnosus 
GG which after exposure to low pH (3.5) prior to digestion, showed a slightly better survival in the 
stomach acid compared to the control (Sumeri et al., 2010). 
In fermented milk, cells should reach a stationary growth phase. According to Lo Curto et al. (2011) 
probiotics challenged with digestive juices survive better when in a stationary phase compared to a 
logarithmic growth phase. Here, this effect was not observed for either of the two tested probiotics. 
Some possible reasons for different results between current and Lo Curto et al. (2011) study are 
differences in used probiotics strains, digestive assay design as well as the way in which cells have been 
grown into stationary phase. In the cited study, after the addition of probiotics to milk or water, samples 
were maintained at 4-6 ˚ C for 6 days, while we fermented milk overnight at 40˚C and submitted samples 
to digestive assay without chilling. It is not clear whether cold storage could improve the resistance of 
probiotics to digestive juices, nevertheless some information in support of this hypothesis can be found 
in the literature. For example, it is known that the temperature of cell growth will have an effect on the 
expression of genes and the physiological characteristics of microorganisms (Montville and Matthews, 
2005). Additionally, cases of the resistance to multiple stressors upon adaptation to a single stressor 
have been documented in the literature. For example, acid adaptation of Bifidobacterium breve resulted 
in a better survival during cold storage of probiotic as well as during exposure to bile and hydrogen 
peroxide (Park et al., 1995). Overall these data suggested that adaptation to stress could be beneficial 
in aiding probiotic survival during passage through upper digestive tract. 
 
Maize starch is used by probiotic manufacturers as a carrier material at a concentration of approx. 90% 
in the powdered product formulation (Winclove probiotics, private communication). In this study, 
digestive survival of L. casei W56 and B. lactis W52 in presence of maize starch was not improved 
compared to control. However, high amylose maize starch was shown to enhance survival of 
Bifidobacterium LaftiTM 8B and 13B during exposure to in vitro as well as in vivo (mice) digestion 
(Wang et al., 1999). Interestingly both of these probiotics had an ability to use amylose from maize 
starch (Wang et al., 1999). The mechanism of the improvement of the digestive survival of probiotics 
in the presence of food source was well explained by Corcoran et al. (2005). These authors found that 
metabolizable sugars have been shown to improve the tolerance of L. rhamnosus GG to acid by 
provision of the energy for the exclusion of protons from cells (Corcoran et al., 2005). Summarising, 
studies suggest that the ability of probiotics to use a present matrix as an energy source might be a factor 
allowing to improve their digestive survival. This was partly supported by findings in our study. The 
total log reduction of stomach juice sensitive L. casei W56 was on average lowest (although not 
significantly) in presence of milk compared to all other treatments (including fermented milk where the 
lactose concentration would be lower), suggesting that the lactose present in milk could have aided 
survival of this probiotic in the stomach juice.  
 
5.3 The effect of the encapsulation on the survival of probiotics during 
in vitro digestion 
In the present study, we have compared two encapsulation approaches- powder and broth. Most 
of the reviewed studies have used freshly grown and harvested cells for encapsulation (the broth 
method). Encapsulation of the powder might however make commercial sense, since the population of 
encapsulated probiotics declines during storage (Yeung et al., 2016). In this study we found that the 
encapsulation did not improve the overall survival of studied probiotics using either of the probiotic 
strains or encapsulation. These data do not generally agree well with the literature reviewed by Shiori 
(2017). Also, in recent published research papers, alginate-chitosan encapsulation is claimed as an 
effective means of protecting probiotics: nevertheless, overall results show that the level of protection 
is limited.      
For example, Yeung et al (2016) encapsulated B. infantis UMA299 into alginate-chitosan using an 
injection-gelation method and observed that the encapsulation provided improved protection aginst the 
action of stomach juice (by 1.3 log cfu compared to control), but not to duodenum juice (Yeung et al., 
2016). In the present study we also noted a significant improvement (by 3.2 log cfu) of L. casei W56 in 
stomach juice compared to the control when probiotic powder was encapsulated.  Nevertheless, overall 
survival did not improve due to increased sensitivity of encapsulated probiotic to duodenal and ileal 
juice (an increase of log reduction compared to control by 1.5 and 3.2 log cfu respectively; see 
supplementary information). Furthermore, for encapsulates containing broth-grown L. casei W56, 
survival in stomach or any other digestive stage was not improved compared to control and total log 
reduction was significantly greater compared to the control. 
In another study, authors investigated the survival of L. plantarum ATCC 8014 encapsulated into 
aliginate-chitosan using electrospraying (Zaeim et al., 2017). They found that overall, the survival of 
the probiotic was improved compared to free cells, but only by ~0.9 log cfu. This improvement was of 
a similar magnitude to one observed for broth-grown, encapsulated B. lactis W52 (total log reduction 
decreased compared to control by 1.1 log cfu).  
5.4 The effect of the presence and concentration of prebiotics on 
survival of probiotics during in vitro digestion 
 It has been shown that probiotic survival in the digestive juices may be improved using 
prebiotics proportionally to applied prebiotic concentration (Haghshenas et al., 2015; Kingwatee et al., 
2014; Sanchez et al., 2014). In the present study, we did not observe an improvement of survival in 
digestive liquids with increased concentration of either inulin or FOS. Furthermore, the total log 
reduction seen upon application of prebiotics in our in vitro digestion, was decreased by a maximum of 
1.4 log cfu. Clearly this decrease was lower compared to what would be expected based on the literature 
(on application of prebiotic concentration ≥0.1 % the log reduction decreased from 2 to ~4 log cfu in 
studies by Haghshenas et al. (2015); Kingwatee et al., (2014) and Sanchez et al. (2014)).  
It is not clear why we did not see a substantial improvement of probiotic survival in the presence of 
prebiotics. One of the possible reasons could be mentioned above (case of starch and glucose) ability 
of probiotics to metabolise substances as energy source. In this study we did not focus on probiotic 
metabolism but only at the evaluation of different approaches for the improvement of probiotic survival. 
Nevertheless, obtained results and published literature data both indicate that probiotic metabolism 
could be one of the factors contributing to probiotic stress resistance and should therefore be a fruitful 
subject for further research. 
6. Conclusions and recommendations for further work 
We report the survivability of L. casei W56 and B. lactis W52 in the presence and absence of food 
matrices, prebiotics and upon encapsulation during passage through simulated selected parts of the 
human digestive tract. Although improvements in the digestive survival of B. lactis W52 were achieved 
by application of milk and fermented milk, no solution seemed to improve viability of L. casei W56. 
Hence, neither of examined methods could be recommended as a universal solution for the 
improvement of probiotic survival during passage through upper parts of the digestive tract.  
Findings presented in this work suggest that in a choice of suitable method for the digestive survival 
improvement, probiotic characteristics play an important role. In the course of this study we have found 
that studied probiotics featured a different survival behaviour. While L. casei W56 was sensitive to 
stomach juice, B. lactis W52 was relatively resistant to stomach juice but declined in the presence of 
duodenum juice. Interestingly, B. lactis W52 survived the digestion well in the presence of matrices 
that contained low level of fat (milk and fermented milk, 3.6 %). This finding indicated that the 
interaction of bile with fat might have minimised the losses of B. lactis W52 in the duodenum juice.  
Another important characteristic of probiotics that may improve their ability to survive through upper 
digestive tract is the use of the matrix components as an energy source. Prebiotics, and maize starch, as 
well as metabolizable sugars may be used by probiotics as food and consequently provide energy for 
removal of protons from cells (as shown for glucose by Corcoran et al. (2005)), improving resistance 
to gastric acid. Although this study did not focus on the characterisation of probiotic metabolism, 
obtained results, highlighted that the ability to use the surrounding matrix as a food source might be of 
key interest if the improvement of the probiotic survivability through human digestive tract is sought.  
Given the results of these studies, probiotic manufacturers could consider focusing on the development 
of suspension protocols for sold probiotic powders that could be applied by the consumers at home. 
General protocol for suspension of probiotic powder recommended by many manufacturers is to mix it 
with water prior to ingestion. Based on the results presented here, we could recommend using whole 
milk instead. Further research into optimisation of such protocols would be of benefit to investigate 
how different acid sensitive probiotics may be delivered effectively to the intestines.  
This research highlighted that to understand mechanisms governing probiotic survival in upper 
gastrointestinal tract and effectively enhance it, still more research is required. Optimisation of probiotic 
survival in studies investigating health benefits of probiotics may be an important factor addressing to 
date observed discrepancies in results of reported human trials (as noted by e.g. Kasińska and Drzewoski 
(2015)). 
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